PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 5, 2026Cancer Research0 citations

Abstract 4986: Identification of tumor microenvironment for high infiltration of lymphocytes in triple negative breast cancer

View Full Paper
SCSowon ChoiHLHee Jin LeeBJByung-Kwan Jeong

Key Points

  • The aim is to understand the role of macrophage subtypes in enhancing lymphocyte infiltration in triple-negative breast cancer.
  • Analyzed treatment-naïve, early-stage TNBC samples from 21 patients.
  • Utilized single-cell-resolution spatial transcriptomics on FFPE tissue microarray blocks.
  • Classified patients into high and low TIL groups based on strict thresholds.
  • Clustered cell types and identified spatial domains using the Xenium 5K platform.
  • Identified 12 spatial domains in TNBC samples, including tumor center and edge.
  • Found that macrophage subtype MC2 with low PLAUR expression is enriched in high TIL regions.
  • Demonstrated that high TIL tumors support normal IFNG-signaling pathways, enhancing macrophage function.

Abstract

Abstract Elucidating the roles of intra-tumoral macrophage subtypes that promote a high-TIL microenvironment in triple-negative breast cancer. High levels of tumor-infiltrating lymphocytes (TILs) within the stromal compartment are associated with favorable prognosis and improved response to immune checkpoint blockade in triple-negative breast cancer (TNBC). To elucidate the mechanisms underlying the divergence between TIL-high and TIL-low tumor microenvironments (TMEs), we analyzed treatment-naïve, early-stage TNBC samples. We profiled the TME of 21 patients using single-cell-resolution spatial transcriptomics on FFPE tissue microarray blocks. Patients were classified into high TIL group with over 60% ratio of TIL in stroma. sTILs (0-100%) were evaluated on H 30% cutoffs associated with distant RFS. Using this classification, 11 patients were assigned to the TIL-high group and 10 to the TIL-low group. We clustered 40 cell types for TNBC samples using Xenium 5K platform and identified 12 spatial domains by uncovering recurrent cellular neighborhoods (RCNs) that share similar spatial patterns using SCIMAP (v2. 2. 11). Among those 12 spatial domains, domain 9 and domain 0 represented tumor center and tumor edge, respectively. We identified 10 myeloid cell subtypes and discovered macrophage subtype MC2 expressing LDHA and PLAUR are enriched specifically in tumor domains consisting of domain 9 and 0. Interestingly, the MC2 (LDHAPLAUR) subtype present low PLAUR expression in TIL-high group compared to TIL-low group in tumor domains. Although the proportion of infiltrating MC2 (LDHAPLAUR) macrophages within tumor domains was higher in the TIL-high group compared with the TIL-low group, the expression level of PLAUR within MC2 cells was paradoxically lower in the TIL-high group. Additionally, the MC2 (LDHAPLAUR) expressed more IFN-stimulated genes such as CXCL9, GBP5, and IRF1 in TIL-high group compared to TIL-low group. PLAUR has been known for inducing HIF1A highly in tumor microenvironment. As HIF1A hinders IFNG-signaling important to establish TIL-high environments, high expression of PLAUR promotes inhibition of IFNG-signaling in macrophages. So, low expression of PLAUR for MC2 in TIL-high group helps normal IFNG-signaling pathways in macrophages. Taken together, these findings indicate MC2 macrophages located in both the cancer center and edge regions showed reduced PLAUR expression, rendering them less susceptible to HIF1A-driven suppression and allowing sustained IFNG-signaling in high-TIL tumors. This suggests that these MC2 cells help establish an intra-tumoral environment conducive to TIL infiltration by continuously supplying CXCL9, CXCL10, and CXCL11. Citation Format: Sowon Choi, Hee Jin Lee, Byung-Kwan Jeong, Hyun Je Kim. Identification of tumor microenvironment for high infiltration of lymphocytes in triple negative breast cancer abstract. In: Proceedings of the American Association for Cancer Research Annual Meeting 2026; Part 1 (Regular Abstracts) ; 2026 Apr 17-22; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2026;86 (7 Suppl): Abstract nr 4986.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Choi et al. (2026) studied this question.

synapsesocial.com/papers/69d1fd8ea79560c99a0a3a03https://doi.org/10.1158/1538-7445.am2026-4986
Ask AI
Helpful
Bookmark
Share
View Full Paper